Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
What gastroenterologists should know about testing patients with eosinophilic esophagitis for food allergies

Philpott H, Royce S, Thien F, Nandurkar S, Gibson P

(2015), Clin Gastroenterol Hepatol, 13(5), 1029-30

IgG and EoE: too soon for a paradigm shift away from IgE

Philpott H, Royce S, Nandurkar S, Thien F, Gibson P

(2015), Gastroenterology, 148(2), 453-4

Seasonal recurrence of food bolus obstruction in eosinophilic esophagitis

Philpott HL, Nandurkar S, Thien F, Bloom S, Lin E, Goldberg R, Boyapati R, Finch A, Royce SG, Gibson PR

(2015), Intern Med J, 45(9), 939-43

Seasonality in eosinophilic oesophagitis and food bolus obstruction - what about recurrent episodes?

Philpott H, Nandurkar S, Royce SG, Gibson PR

(2015), Aliment Pharmacol Ther, 42(7), 936

Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery

Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Leach S, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Jakobovits SL, Florin TH, Gibson PR, Debinski H, Macrae FA, Samuel D, Kronborg I, Radford-Smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Day AS, Desmond PV, Gearry RB

(2015), Gastroenterology, 148(5), 938-947.e1

Sleep and physical activity measured by accelerometry in Crohn's disease

van Langenberg DR, Papandony MC, Gibson PR

(2015), Aliment Pharmacol Ther, 41(10), 991-1004

Metabolomics as a tool for diagnosis and monitoring in coeliac disease

Ryan D, Newnham E, Prenzler PD, Gibson PR

(2015), Metabolomics, 11(4), 980-90

Eosinophilic esophagitis: a clinicopathological review

Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG

(2015), Pharmacol Ther, 146, 12-22

A new shift in the paradigm of treatment for the irritable bowel syndrome?

Peters SL, Gibson PR

(2015), Aliment Pharmacol Ther, 41(12), 1296

The impact of symptoms, irritable bowel syndrome pattern and diagnostic investigations on the diagnostic delay of Crohn's disease: a prospective study

Maconi G, Orlandini L, Asthana AK, Sciurti R, Furfaro F, Bezzio C, de Franchis R

(2015), Dig Liver Dis, 47(8), 646-51

Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications

Kitson MT, Roberts SK, Colman JC, Paul E, Button P, Kemp W

(2015), Scand J Gastroenterol, 50(4), 462-9

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Gibson PR, Muir JG

(2015), Gut, 64(1), 93-100

Other dietary confounders: FODMAPS et al.

Gibson PR, Muir JG, Newnham ED

(2015), Dig Dis, 33(2), 269-76

Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: a pilot study

Garg M, Burrell LM, Velkoska E, Griggs K, Angus PW, Gibson PR, Lubel JS

(2015), J Renin-Angiotensin-Aldosterone Syst, 16(3), 559-69

Crohn's disease management after intestinal resection: a randomised trial

De Cruz P, Kamm MA, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Gibson PR, Sparrow M, Leong RW, Florin TH, Gearry RB, Radford-Smith G, Macrae FA, Debinski H, Selby W, Kronborg I, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV

(2015), Lancet, 385(9976), 1406-17

Changing face of care for patients with moderate to severe inflammatory bowel disease: the role of specialist nurses in the governance of anti-TNF prescribing

Connell WR, Samyue T, Gibson PR, Lachal S, Moore GT, Macrae FA, Van Langenberg DR

(2015), Intern Med J, 45(11), 1161-6

Long-term outcomes of colectomy surgery among patients with ulcerative colitis

Brown C, Gibson PR, Hart A, Kaplan GG, Kachroo S, Ding Q, Hautamaki E, Fan T, Black CM, Hu X, Beusterien K

(2015), Springerplus, 4, 573

Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma

Seggewiss-Bernhardt R, Bargou RC, Goh YT, Stewart AK, Spencer A, Alegre A, Bladé J, Ottmann OG, Fernandez-Ibarra C, Lu H, Pain S, Akimov M, Iyer SP

(2015), Cancer, 121(13), 2185-92

The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components

Seed CR, Wong J, Polizzotto MN, Faddy H, Keller AJ, Pink J

(2015), Vox Sang, 109(1), 11-7

BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs

Sadler AJ, Rossello FJ, Yu L, Deane JA, Yuan X, Wang D, Irving AT, Kaparakis-Liaskos M, Gantier MP, Ying H, Yim HC, Hartland EL, Notini AJ, de Boer S, White SJ, Mansell A, Liu JP, Watkins DN, Gerondakis S, Williams BR, Xu D

(2015), Proc Natl Acad Sci USA, 112(5), 1535-40

319 320 321 322 323